• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

7T-MP2RAGEΔT1 图检测非增强型多发性硬化病变中的血脑屏障破坏。

Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.

机构信息

Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

University of Maryland School of Medicine, Baltimore, Maryland, United States of America.

出版信息

PLoS One. 2021 Apr 26;16(4):e0249973. doi: 10.1371/journal.pone.0249973. eCollection 2021.

DOI:10.1371/journal.pone.0249973
PMID:33901207
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8075220/
Abstract

Although the blood-brain barrier (BBB) is altered in most multiple sclerosis (MS) lesions, gadolinium enhancement is seen only in acute lesions. In this study, we aimed to investigate gadolinium-induced changes in T1 relaxation time in MS lesions on 7-tesla (7T) MRI as a means to quantify BBB breakdown in non-enhancing MS lesions. Forty-seven participants with MS underwent 7T MRI of the brain with a magnitude-prepared rapid acquisition of 2 gradient echoes (MP2RAGE) sequence before and after contrast. Subtraction of pre- and post-contrast T1 maps was used to measure T1 relaxation time change (ΔT1) from gadolinium. ΔT1 values were interrogated in enhancing white matter lesions (ELs), non-enhancing white matter lesions (NELs), and normal appearing white matter (NAWM) and metrics were compared to clinical data. ΔT1 was measurable in NELs (median: -0.139 (-0.304, 0.174) seconds; p < 0.001) and was negligible in NAWM (median: -0.001 (-0.036, 0.155) seconds; p = 0.516). Median ΔT1 in NELs correlated with disability as measured by Expanded Disability Status Scale (EDSS) (rho = -0.331, p = 0.026). Multiple measures of NEL ΔT1 variability also correlated with EDSS. NEL ΔT1 values were greater and more variable in patients with progressive forms of MS and greater in those not on MS treatment. Measurement of the changes in T1 relaxation time caused by contrast on 7T MP2RAGE reveals clinically relevant evidence of BBB breakdown in NELs in MS. This data suggests that NEL ΔT1 should be evaluated further as a potential biomarker of persistently disrupted BBB in MS. Although the blood-brain barrier (BBB) is altered in most multiple sclerosis (MS) lesions, gadolinium enhancement is seen only in acute lesions. In this study, we aimed to investigate gadolinium-induced changes in T1 relaxation time in MS lesions on 7-tesla (7T) MRI as a means to quantify BBB breakdown in non-enhancing MS lesions. Forty-seven participants with MS underwent 7T MRI of the brain with a magnitude-prepared rapid acquisition of 2 gradient echoes (MP2RAGE) sequence before and after contrast. Subtraction of pre- and post-contrast T1 maps was used to measure T1 relaxation time change (ΔT1) from gadolinium. ΔT1 values were interrogated in enhancing white matter lesions (ELs), non-enhancing white matter lesions (NELs), and normal appearing white matter (NAWM) and metrics were compared to clinical data. ΔT1 was measurable in NELs (median: -0.139 (-0.304, 0.174) seconds; p < 0.001) and was negligible in NAWM (median: -0.001 (-0.036, 0.155) seconds; p = 0.516). Median ΔT1 in NELs correlated with disability as measured by Expanded Disability Status Scale (EDSS) (rho = -0.331, p = 0.026). Multiple measures of NEL ΔT1 variability also correlated with EDSS. NEL ΔT1 values were greater and more variable in patients with progressive forms of MS and greater in those not on MS treatment. Measurement of the changes in T1 relaxation time caused by contrast on 7T MP2RAGE reveals clinically relevant evidence of BBB breakdown in NELs in MS. This data suggests that NEL ΔT1 should be evaluated further as a potential biomarker of persistently disrupted BBB in MS.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/3f1d042f6424/pone.0249973.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/c99d9386b554/pone.0249973.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/1673c74b8315/pone.0249973.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/0b5959e92ed1/pone.0249973.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/3f1d042f6424/pone.0249973.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/c99d9386b554/pone.0249973.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/1673c74b8315/pone.0249973.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/0b5959e92ed1/pone.0249973.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c2a/8075220/3f1d042f6424/pone.0249973.g004.jpg
摘要

虽然血脑屏障(BBB)在大多数多发性硬化症(MS)病变中发生改变,但仅在急性病变中可见钆增强。在这项研究中,我们旨在研究 7 特斯拉(7T)MRI 上 MS 病变中钆诱导的 T1 弛豫时间变化,作为量化非增强 MS 病变中 BBB 破裂的一种手段。47 名 MS 患者在对比前后接受了大脑的 7T MRI 检查,采用幅度准备快速获取 2 个梯度回波(MP2RAGE)序列。通过减去对比前后的 T1 图谱来测量来自钆的 T1 弛豫时间变化(ΔT1)。在增强的白质病变(ELs)、非增强的白质病变(NELs)和正常表现的白质(NAWM)中检查ΔT1 值,并将指标与临床数据进行比较。在 NELs 中可以测量到ΔT1(中位数:-0.139(-0.304,0.174)秒;p<0.001),在 NAWM 中则可以忽略不计(中位数:-0.001(-0.036,0.155)秒;p=0.516)。NELs 中ΔT1 的中位数与扩展残疾状态量表(EDSS)所测量的残疾相关(rho=-0.331,p=0.026)。NELΔT1 变异性的多种测量也与 EDSS 相关。进展型 MS 患者的 NELΔT1 值更高且更具变异性,未接受 MS 治疗的患者的 NELΔT1 值更高。7T MP2RAGE 对比后 T1 弛豫时间变化的测量显示,MS 中 NELs 存在与临床相关的 BBB 破裂证据。该数据表明,NELΔT1 应作为 MS 中持续破坏的 BBB 的潜在生物标志物进一步评估。

相似文献

1
Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.7T-MP2RAGEΔT1 图检测非增强型多发性硬化病变中的血脑屏障破坏。
PLoS One. 2021 Apr 26;16(4):e0249973. doi: 10.1371/journal.pone.0249973. eCollection 2021.
2
Quantitative T1 mapping detects blood-brain barrier breakdown in apparently non-enhancing multiple sclerosis lesions.定量 T1 映射可检测到表观无强化多发性硬化病变中的血脑屏障破坏。
Neuroimage Clin. 2023;40:103509. doi: 10.1016/j.nicl.2023.103509. Epub 2023 Sep 12.
3
7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis.7T MPFLAIR 与 MP2RAGE 定量多发性硬化病变体积的比较。
J Neuroimaging. 2020 Jul;30(4):531-536. doi: 10.1111/jon.12718. Epub 2020 Jun 22.
4
Blood-brain barrier permeability of normal appearing white matter in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症中正常外观的白质的血脑屏障通透性。
PLoS One. 2013;8(2):e56375. doi: 10.1371/journal.pone.0056375. Epub 2013 Feb 18.
5
Personalized maps of T1 relaxometry abnormalities provide correlates of disability in multiple sclerosis patients.个性化 T1 弛豫率异常图谱为多发性硬化症患者的残疾提供相关信息。
Neuroimage Clin. 2023;37:103349. doi: 10.1016/j.nicl.2023.103349. Epub 2023 Feb 13.
6
Periventricular gradient of T tissue alterations in multiple sclerosis.多发性硬化症中T组织改变的脑室周围梯度
Neuroimage Clin. 2022;34:103009. doi: 10.1016/j.nicl.2022.103009. Epub 2022 Apr 16.
7
Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.定量磁敏感图定量分析多发性硬化正常表现白质的易损性。
AJR Am J Roentgenol. 2017 Oct;209(4):889-894. doi: 10.2214/AJR.16.16851. Epub 2017 Jul 13.
8
Within-lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis.病灶内定量 MRI 参数的差异可预测多发性硬化症的对比增强。
J Magn Reson Imaging. 2013 Dec;38(6):1454-61. doi: 10.1002/jmri.24107. Epub 2013 Apr 1.
9
Abnormal blood-brain barrier water exchange in chronic multiple sclerosis lesions: A preliminary study.慢性多发性硬化病变中血脑屏障水交换异常:一项初步研究。
Magn Reson Imaging. 2020 Jul;70:126-133. doi: 10.1016/j.mri.2020.04.017. Epub 2020 Apr 28.
10
Evaluation of the Blood-Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI.7T MRI 评价多发性硬化症钆增强环病变中的血脑屏障、脱髓鞘和神经退行性变。
J Magn Reson Imaging. 2024 Mar;59(3):941-951. doi: 10.1002/jmri.28847. Epub 2023 Jun 5.

引用本文的文献

1
Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis.炎症改变多发性硬化症中髓样细胞和少突胶质细胞的铁处理。
Acta Neuropathol Commun. 2025 Jun 4;13(1):124. doi: 10.1186/s40478-025-02020-0.
2
The use of 7T MRI in multiple sclerosis: review and consensus statement from the North American Imaging in Multiple Sclerosis Cooperative.7T磁共振成像在多发性硬化症中的应用:北美多发性硬化症协作组的综述与共识声明
Brain Commun. 2024 Oct 9;6(5):fcae359. doi: 10.1093/braincomms/fcae359. eCollection 2024.
3
Neuroimaging to monitor worsening of multiple sclerosis: advances supported by the grant for multiple sclerosis innovation.

本文引用的文献

1
7T MPFLAIR versus MP2RAGE for Quantifying Lesion Volume in Multiple Sclerosis.7T MPFLAIR 与 MP2RAGE 定量多发性硬化病变体积的比较。
J Neuroimaging. 2020 Jul;30(4):531-536. doi: 10.1111/jon.12718. Epub 2020 Jun 22.
2
The features of cerebral permeability and perfusion detected by dynamic contrast-enhanced magnetic resonance imaging with Patlak model in relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症中采用Patlak模型的动态对比增强磁共振成像检测脑通透性和灌注的特征
Ther Clin Risk Manag. 2019 Feb 4;15:233-240. doi: 10.2147/TCRM.S189598. eCollection 2019.
3
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.
用于监测多发性硬化症病情恶化的神经影像学:多发性硬化症创新基金支持下的进展
Front Neurol. 2023 Dec 1;14:1319869. doi: 10.3389/fneur.2023.1319869. eCollection 2023.
4
Evaluation of the Blood-Brain Barrier, Demyelination, and Neurodegeneration in Paramagnetic Rim Lesions in Multiple Sclerosis on 7 Tesla MRI.7T MRI 评价多发性硬化症钆增强环病变中的血脑屏障、脱髓鞘和神经退行性变。
J Magn Reson Imaging. 2024 Mar;59(3):941-951. doi: 10.1002/jmri.28847. Epub 2023 Jun 5.
5
Imaging blood-brain barrier dysfunction: A state-of-the-art review from a clinical perspective.成像血脑屏障功能障碍:从临床角度的最新综述
Front Aging Neurosci. 2023 Apr 17;15:1132077. doi: 10.3389/fnagi.2023.1132077. eCollection 2023.
6
Correction: Blood-brain barrier breakdown in non-enhancing multiple sclerosis lesions detected by 7-Tesla MP2RAGE ΔT1 mapping.更正:通过7特斯拉MP2RAGE ΔT1映射检测到的非强化型多发性硬化症病变中的血脑屏障破坏。
PLoS One. 2022 Feb 22;17(2):e0264452. doi: 10.1371/journal.pone.0264452. eCollection 2022.
作为慢性活动性多发性硬化病变的磁共振成像标志物,病变呈缓慢扩大/演变。
Mult Scler. 2019 Dec;25(14):1915-1925. doi: 10.1177/1352458518814117. Epub 2018 Dec 19.
4
Improved Visualization of Cortical Lesions in Multiple Sclerosis Using 7T MP2RAGE.使用 7T MP2RAGE 提高多发性硬化症皮质病变的可视化效果。
AJNR Am J Neuroradiol. 2018 Mar;39(3):459-466. doi: 10.3174/ajnr.A5534. Epub 2018 Feb 8.
5
The blood-brain barrier in systemic inflammation.全身炎症反应中的血脑屏障。
Brain Behav Immun. 2017 Feb;60:1-12. doi: 10.1016/j.bbi.2016.03.010. Epub 2016 Mar 16.
6
T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.T1 - 黑洞中的阈值增加了多发性硬化症患者的临床 - 放射学相关性。
PLoS One. 2015 Dec 11;10(12):e0144693. doi: 10.1371/journal.pone.0144693. eCollection 2015.
7
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.对白质多发性硬化斑块动态性质的临床与病理见解。
Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.
8
New multiple sclerosis phenotypic classification.新的多发性硬化症表型分类。
Eur Neurol. 2014;72 Suppl 1:1-5. doi: 10.1159/000367614. Epub 2014 Sep 26.
9
The issues and tentative solutions for contrast-enhanced magnetic resonance imaging at ultra-high field strength.超高场强对比增强磁共振成像的问题与初步解决方案
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2014 Nov-Dec;6(6):559-73. doi: 10.1002/wnan.1291. Epub 2014 Sep 4.
10
MP2RAGE provides new clinically-compatible correlates of mild cognitive deficits in relapsing-remitting multiple sclerosis.MP2RAGE为复发缓解型多发性硬化症中轻度认知缺陷提供了新的临床兼容关联指标。
J Neurol. 2014 Aug;261(8):1606-13. doi: 10.1007/s00415-014-7398-4. Epub 2014 Jun 10.